IPP Bureau
Fermenta Biotech receives EU GMP Certification for its Dahej facility
By IPP Bureau - September 23, 2024
This approval reflects company’s unwavering commitment that the quality assurance
Pfizer and BioNTech receive positive CHMP opinion for Omicron KP.2-adapted COVID-19
By IPP Bureau - September 23, 2024
Doses will be ready to ship to applicable European Union (EU) member states as soon as possible upon European Commission (EC) authorization
Fasenra recommended for approval in the EU by CHMP for treatment of EGPA
By IPP Bureau - September 23, 2024
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Aster DM Healthcare to launch the Rs. 220 crore Women & Children’s Hospital in Hyderabad
By IPP Bureau - September 22, 2024
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Briefs: Biocon, Aarti Drugs and Glenmark Pharmaceuticals
By IPP Bureau - September 22, 2024
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
Pharmaceutical sector set for 8-10% revenue growth this fiscal: CRISIL
By IPP Bureau - September 20, 2024
Stable profits, low leverage to keep credit profiles comfortable
AstraZeneca Pharma India to launch Palivizumab (Synagis) in October 2024
By IPP Bureau - September 20, 2024
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease
Suven Pharmaceuticals names Vivek Sharma as Executive Chairman
By IPP Bureau - September 20, 2024
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Wockhardt's Zaynich cures complex case of meningitis caused by pan-drug resistant super-bug under compassionate use
By IPP Bureau - September 20, 2024
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
Briefs: Fermenta Biotech and Family Care Hospitals
By IPP Bureau - September 20, 2024
Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate
Abbott India inks non-exclusive patent license agreement with Takeda for Vonoprazan
By IPP Bureau - September 20, 2024
This license will enable Abbott to enhance access to this novel therapy to more patients across India
MGC inks agreement to revolutionize allergy care
By IPP Bureau - September 20, 2024
Dr. Girish Budhrani recognised with ACOIN Gujarat Chapter Oration
By IPP Bureau - September 20, 2024
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
Briefs: Dr. Reddy's Laboratories and Torrent Pharmaceuticals
By IPP Bureau - September 20, 2024
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
Merck receives positive EU CHMP opinions for pembrolizumab regimens for gynecologic cancers
By IPP Bureau - September 20, 2024
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma
